Kam, Ning http://orcid.org/0000-0003-1240-4179
Perera, Kanila http://orcid.org/0000-0002-0421-196X
Zomer, Ella http://orcid.org/0000-0002-9993-4297
Liew, Danny http://orcid.org/0000-0002-0131-623X
Ademi, Zanfina http://orcid.org/0000-0002-0625-3522
Article History
First Online: 13 August 2020
Declarations
:
: The author(s) received no financial support for the research, authorship, and/or publication of this article.
: Ning Kam, Kanila Perera and Zanfina Ademi have no conflicts of interest to declare. Ella Zomer has received grants from Amgen, AstraZeneca, Pfizer and Shire, outside the submitted work. Danny Liew declares grant support from Abbvie, Astellas, AstraZeneca, Bristol-Myers Squibb, CSL-Behring, Novartis, Pfizer, Sanofi and Shire, and past participation in advisory boards at Abbvie, Astellas, AstraZeneca, Bristol-Myers Squibb, Novartis, Pfizer and Sanofi, outside the submitted work.
: Not applicable.
: Not applicable.
: All data generated or analysed during this study are included in this published article.
: Custom code is available from the corresponding author upon reasonable request.
: ZA conceived the idea and NK, KP, EZ and DL contributed to the design of the work. All authors contributed to the acquisition, analysis or interpretation of data for the work. NK drafted the manuscript. ZA, EZ and DL critically revised the manuscript. All authors gave final approval and agree to be accountable for all aspects of the work ensuring integrity and accuracy.
: Ethics approval was not required as this study relied on published and publicly available data.